IX1 Stock Overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for IX1 from our risk checks.
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$460.20 |
| 52 Week High | US$536.80 |
| 52 Week Low | US$349.20 |
| Beta | 1.26 |
| 1 Month Change | -5.70% |
| 3 Month Change | -3.56% |
| 1 Year Change | 5.43% |
| 3 Year Change | 0.17% |
| 5 Year Change | 124.43% |
| Change since IPO | 11,776.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| IX1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.4% | 1.7% | 1.7% |
| 1Y | 5.4% | -7.7% | 2.3% |
Return vs Industry: IX1 exceeded the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: IX1 exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| IX1 volatility | |
|---|---|
| IX1 Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IX1 has not had significant price volatility in the past 3 months.
Volatility Over Time: IX1's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| IX1 fundamental statistics | |
|---|---|
| Market cap | €38.34b |
| Earnings (TTM) | €789.61m |
| Revenue (TTM) | €3.42b |
48.6x
P/E Ratio11.2x
P/S RatioIs IX1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IX1 income statement (TTM) | |
|---|---|
| Revenue | US$3.66b |
| Cost of Revenue | US$1.47b |
| Gross Profit | US$2.19b |
| Other Expenses | US$1.34b |
| Earnings | US$845.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 10.17 |
| Gross Margin | 59.82% |
| Net Profit Margin | 23.08% |
| Debt/Equity Ratio | 63.9% |
How did IX1 perform over the long term?
See historical performance and comparison